Chemomab Therapeutics (CMMB) - Bathi resik saben saham (EPS TTM)

Simbol lan logo merek Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics (CMMB), an Israeli developer of inflammatory liver disease therapies, is demonstrating steady research progress. Net profit per share dynamics confirm the current trajectory, where -1.01 shows the value of this parameter. Risks are being minimized through the diversification of antibody clinical trial stages and the engagement of external CROs to ensure the efficient execution of medical trials without supply chain disruptions.

CMMB (chemomab.com) riwayat Bathi saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 16.11.2026

Rincian metrik komprehensif lan analitis Chemomab (CMMB)

Analisis umum perusahaan:Chemomab Therapeutics Ltd. (CMMB)
Produk seri Chemomab Therapeutics Ltd

Chemomab Therapeutics (CMMB) specializes in developing innovative drugs for the treatment of rare fibro-inflammatory pathologies. This indicator measures the portion of net income attributable to a single common share over a rolling year. Such a metric allows investors to assess the actual efficiency of business capitalization without accounting for quarterly fluctuations. Amid high demand for orphan drugs, this figure reflects the company's ability to convert research and development into revenue. By analyzing the trend of annual net income per share, one can identify the risk of margin compression or confirm fundamental growth.

Pesaing Chemomab Therapeutics (CMMB)

VRTX: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben siji saham sajrone 12 wulan pungkasan ALNY|INSM: Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan BBIO (BridgeBio)|Bathi saben saham sajrone rolas wulan pungkasan bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Bathi saben siji saham sajrone 12 wulan pungkasan|Arcturus Therapeutics - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajroning taun lumaku ETON (Eton Pharmaceuticals)|KMDA: Bathi resik saben saham (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan abeonatherapeutics.com|MREO: Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) PLX|Bathi resik saben saham sajrone 12 wulan pungkasan Pliant Therapeutics, Inc. PLRX|Bathi resik saben saham (EPS TTM) APLT (Applied Therapeutics Inc.)|Bathi resik saben saham (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Bathi resik saben saham (EPS TTM)|AYTU - Bathi resik saben saham (EPS TTM)|SRx Health (SRXH) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Polyrizon Ltd. (PLRZ)|Bathi resik saben saham sajrone 12 wulan pungkasan AEZS|Bathi resik saben saham sajrone 12 wulan pungkasan Cyclo Therapeutics Inc. (CYTH)|Bathi resik saben saham sajrone 12 wulan pungkasan INZY (inozyme.com)|RPHM - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) CSCI (cosciensbio.com)